Parajuli Stephany Ruiz UCI 21-212: A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician’s Choice and Pembrolizumab …

2025年7月24日 · The reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced …

Official Title: Beamion BCGC-1: A Phase Ib Dose Escalation and Phase II Dose Optimization, Randomized, Open-Label, Multicenter Trial of Oral Zongertinib (BI 1810631) in Combination …

Talzenna For Metastatic Breast Cancer: A Promising Treatment Option At Uci Metastatic breast cancer is one of the most challenging stages of breast cancer, where the disease has spread …

5 天之前 · Antibody-drug conjugates offer targeted power but come with distinct side effects. Learn how clinicians are tackling toxicity while maximizing efficacy in metastatic breast cancer.

4 天之前 · Two antibody-drug conjugates, Enhertu (trastuzumab deruxtecan) and Trodelvy (sacituzumab govitecan), delayed disease progression for women receiving initial treatment for …

2025年5月12日 · This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. …

2025年7月24日 · Gain insight into how triple-negative breast cancer spreads and the advanced strategies used to diagnose, treat, and manage the disease in its metastatic stage.

-No prior chemotherapy for advanced or metastatic breast cancer. Subjects who have received chemotherapy in the neo-adjuvant or adjuvant setting are eligible, as long as they have had a …

Metastatic breast cancer is stage IV breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body. Experts at the Kimmel Cancer Center at Johns …